ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 613,90
0,56%
Dow Jones
38 778,10
0,00%
DAX
18 110,84
0,21%
Brent Oil
83,705
-0,23%
Bitcoin
64 900,70
-2,37%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. West Pharmaceutical Services Inc (WST)

  7. West Pharmaceutical Services Inc (WST) Actualités

WST

West Pharmaceutical Serv... (WST)

West Pharmaceutical Services Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:WST
DateHeureSourceTitreSymboleSociété
13/06/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:WSTWest Pharmaceutical Services Inc
29/05/202412h00PR Newswire (US)West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene TherapyNYSE:WSTWest Pharmaceutical Services Inc
28/05/202412h00PR Newswire (US)West to Participate in Upcoming Investor ConferenceNYSE:WSTWest Pharmaceutical Services Inc
22/05/202422h05Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:WSTWest Pharmaceutical Services Inc
10/05/202419h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:WSTWest Pharmaceutical Services Inc
25/04/202412h00PR Newswire (US)West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
11/04/202412h00PR Newswire (US)West to Host First-Quarter 2024 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
01/03/202422h24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNYSE:WSTWest Pharmaceutical Services Inc
28/02/202422h30PR Newswire (US)West to Participate in Upcoming Investor ConferencesNYSE:WSTWest Pharmaceutical Services Inc
20/02/202422h44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:WSTWest Pharmaceutical Services Inc
20/02/202412h00PR Newswire (US)West Announces Second-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
15/02/202413h51Edgar (US Regulatory)Form 8-K - Current reportNYSE:WSTWest Pharmaceutical Services Inc
15/02/202412h00PR Newswire (US)West Announces Fourth-Quarter and Full-Year 2023 ResultsNYSE:WSTWest Pharmaceutical Services Inc
07/02/202414h00PR Newswire (US)West Named to Newsweek's America's Greatest Workplaces 2024 for DiversityNYSE:WSTWest Pharmaceutical Services Inc
01/02/202412h00PR Newswire (US)West to Host Fourth-Quarter and Full-Year 2023 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
24/01/202423h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
21/12/202318h54Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
06/12/202312h00PR Newswire (US)West Announces First-Quarter 2024 DividendNYSE:WSTWest Pharmaceutical Services Inc
04/12/202321h46Dow Jones NewsWest Gets FDA 510(k) Clearance for Vial2Bag Advanced 13mm Admixture DeviceNYSE:WSTWest Pharmaceutical Services Inc
04/12/202321h00PR Newswire (US)West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture DeviceNYSE:WSTWest Pharmaceutical Services Inc
13/11/202313h00GlobeNewswire Inc.Sotera Health Appoints Karen Flynn to Board of DirectorsNYSE:WSTWest Pharmaceutical Services Inc
26/10/202322h26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:WSTWest Pharmaceutical Services Inc
26/10/202312h00PR Newswire (US)West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 DividendNYSE:WSTWest Pharmaceutical Services Inc
23/10/202312h00PR Newswire (US)West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide ConferenceNYSE:WSTWest Pharmaceutical Services Inc
16/10/202312h00PR Newswire (US)West to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA ConferenceNYSE:WSTWest Pharmaceutical Services Inc
12/10/202312h00PR Newswire (US)West to Host Third-Quarter 2023 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
21/09/202322h33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:WSTWest Pharmaceutical Services Inc
27/07/202312h00PR Newswire (US)West Announces Second-Quarter 2023 ResultsNYSE:WSTWest Pharmaceutical Services Inc
13/07/202312h00PR Newswire (US)West to Host Second-Quarter 2023 Conference CallNYSE:WSTWest Pharmaceutical Services Inc
28/06/202322h07Edgar (US Regulatory)Annual Report of Employee Stock Plans (11-k)NYSE:WSTWest Pharmaceutical Services Inc
 Showing the most relevant articles for your search:NYSE:WST

Dernières Valeurs Consultées

EU
EEUE
BNP Paribas Easy MSCI Eu...
NYSE
JXN
Jackson Financial
LSE
BD34
Citi Fun 24
EU
XS0609140529
Rabobank Nederland RB 3....
BIT
P1DDM4
BNP Paribas Issuance
BIT
UC6JXE
Unicredit Bank
AQSE
SLXX.GB
EUR Corp Bond UCITS ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés